Discover
SKIN
SkinHealth Systems Inc.
0.71
1 x 0.51
1 x 0.92
bid
ask
-
0.01
1.25%
01:18 PM
timesize
| Ytd | -49.01% | |
| 1y | -66.41% |
0.70
day range
0.77
0.55
52 week range
2.69
| Open | 0.72 | Prev Close | 0.72 | Low | 0.70 | High | 0.77 | Mkt Cap | 91.86M |
| Vol | 236.82K | Avg Vol | 1.21M | EPS | -0.13 | P/E | N/A | Forward P/E | -9.00 |
| Beta | 0.91 | Short Ratio | 8.46 | Inst. Own | 87.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.72 | 200-d Avg | 1.21 | 1yr Est | 1.72 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -0.12 | -0.15 | -0.03 | -25.00% |
| 2024-08-08 | 2024-06 | -0.05 | -0.1 | -0.05 | -100.00% |
| 2024-08-08 | 2024-06 | -0.05 | N/A | N/A | N/A |
| 2024-05-09 | 2024-03 | -0.14 | -0.1 | 0.04 | 28.57% |
| 2024-05-09 | 2024-03 | -0.14 | N/A | N/A | N/A |
| 2024-03-12 | 2023-12 | -0.11 | -0.07 | 0.04 | 36.36% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-11-13 | Canaccord Genuity | Upgrade | Hold | Hold |
| 2024-08-12 | Canaccord Genuity | Upgrade | Hold | Hold |
| 2024-08-09 | Piper Sandler | Upgrade | Underweight | Underweight |
| 2024-07-26 | Stifel | Upgrade | Hold | Hold |
| 2024-07-11 | Piper Sandler | Upgrade | Underweight | Underweight |
| 2024-05-13 | DA Davidson | Upgrade | Buy | Buy |
Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-04-08 | BECK MARLA MALCOLM | Chief Executive Officer | 1.08M | Stock Award(Grant) |
| 2024-07-07 | CAPELLAS MICHAEL D | Director | 276.15K | Stock Award(Grant) |
| 2024-07-07 | FEW JULIUS | Director | 194.34K | Stock Award(Grant) |
| 2024-11-19 | GRUBER DESIREE | Director | 119.51K | Sale |
| 2024-07-07 | KERRICK MICHELLE C. | Director | 116.76K | Stock Award(Grant) |
| 2024-07-07 | MILLER BRIAN CHRISTOPHER | Director | 169.98K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | FMR, LLC | 18.60M | 26.79M | 14.99% |
| 2024-09-29 | Janus Henderson Group PLC | 11.21M | 16.14M | 9.03% |
| 2024-09-29 | Blackrock Inc. | 5.62M | 8.09M | 4.53% |
| 2024-09-29 | Vanguard Group Inc | 5.54M | 7.97M | 4.46% |
| 2024-09-29 | Braidwell LP | 4.05M | 5.83M | 3.26% |
| 2024-09-29 | Jacobs Levy Equity Management, Inc. | 2.50M | 3.60M | 2.01% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Janus Henderson Contrarian Fund | 11.12M | 16.01M | 8.96% |
| 2024-10-30 | Fidelity Growth Company Fund | 3.85M | 5.54M | 3.10% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 2.70M | 3.89M | 2.17% |
| 2024-10-30 | iShares Russell 2000 ETF | 1.98M | 2.85M | 1.59% |
| 2024-10-30 | Fidelity Growth Company K6 Fund | 1.43M | 2.06M | 1.15% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 1.27M | 1.82M | 1.02% |